Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments



Rating:

Share or cite this content

Citations should be made in the following way:
J. Selby (London, United Kingdom), B. Cushen (London, United Kingdom), P. Patel (London, United Kingdom), R. Rauch (London, United Kingdom), J. Hull (London, United Kingdom). Detection of laryngeal dysfunction in the systematic assessment of severe asthma. 1110

Member's Comments

No comment yet.

Related content which might interest you: Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Is it really severe asthma? A systematic approach to assessment Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment Year: 2019 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Estimating the prevalence of undiagnosed inducible laryngeal obstruction within a severe asthma cohort Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Ultrasonographic assessment of diaphragm dysfunction in acute exacerbations of COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Peripheral airways dysfunction in severe asthma: an evaluation of three complementary methods Source: Eur Respir J 2004; 24: Suppl. 48, 441s Year: 2004 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Diagnosis of small airways dysfunction in patients with asthma. Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020 Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016 Predictors of exercise-induced airways obstruction in patients with mild asthma. Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Prevalence of inducible laryngeal obstruction with breathing pattern disorders and the outcomes of physiotherapy management Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease Year: 2019 The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001 Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021 Year: 2021 Evaluation and management of difficult-to-control asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Effect of persistent asthma on musculoskeletal dysfunction and pain in adults Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems Year: 2010 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: a systematic review Source: Eur Respir Rev, 26 (144) 170026; 10.1183/16000617.0026-2017 Year: 2017 Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adults Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015